2022
DOI: 10.1002/brb3.2592
|View full text |Cite
|
Sign up to set email alerts
|

No optical coherence tomography changes in premanifest Huntington's disease mutation carriers far from disease onset

Abstract: Background: Spectral-domain optical coherence tomography (OCT) may detect retinal changes as a biomarker in neurodegenerative diseases like manifest Huntington's disease (HD). We investigate macular retinal layer thicknesses in a premanifest HD (pre-HD) cohort and healthy controls (HC).Methods: Pre-HD mutation carriers underwent standardized ratings and a preset macular OCT scan. Thickness values were determined for each sector of all macular retinal layers, the mean of all sectors and the mean of the inner ri… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 42 publications
(53 reference statements)
1
2
1
Order By: Relevance
“…The attenuated GCIPL thickness found in our study confirms prior work that identified thinning in both the ganglion cell layer and the inner plexiform layer in individuals with [41,42]. In contrast, our study focused on individuals who were genetically positive and in the prodromal or motor manifest disease stage, and therefore had a more advanced form of HD than the 2 prior which could account for the differences seen in GCIPL thickness.…”
Section: Plos Onesupporting
confidence: 83%
See 3 more Smart Citations
“…The attenuated GCIPL thickness found in our study confirms prior work that identified thinning in both the ganglion cell layer and the inner plexiform layer in individuals with [41,42]. In contrast, our study focused on individuals who were genetically positive and in the prodromal or motor manifest disease stage, and therefore had a more advanced form of HD than the 2 prior which could account for the differences seen in GCIPL thickness.…”
Section: Plos Onesupporting
confidence: 83%
“…HD[40]. Interestingly, GCIPL attenuation was not found by Mazur-Michałek et al and Schmid et al[41,42]. Both papers had slightly different cohorts than our study, with Mazur-Michałek et al studying asymptomatic individuals who were genetically positive for HD and Schmid et al studying both individuals who were genetically positive and in the asymptomatic or the prodromal disease stage…”
contrasting
confidence: 56%
See 2 more Smart Citations